CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Clene Inc. - CLNN CFD

    0.3824
    5.58%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0091
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Clene Inc. ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.405
    Open* 0.4085
    1-Year Change* -59.08%
    Day's Range* 0.377 - 0.4085
    52 wk Range 0.36-1.99
    Average Volume (10 days) 252.08K
    Average Volume (3 months) 8.99M
    Market Cap 58.56M
    P/E Ratio -100.00K
    Shares Outstanding 128.42M
    Revenue 718.00K
    EPS -0.48
    Dividend (Yield %) N/A
    Beta 0.54
    Next Earnings Date Mar 11, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 0.3824 -0.0261 -6.39% 0.4085 0.4085 0.3718
    Dec 7, 2023 0.4050 -0.0134 -3.20% 0.4184 0.4184 0.3884
    Dec 6, 2023 0.3982 -0.0043 -1.07% 0.4025 0.4084 0.3914
    Dec 5, 2023 0.3905 -0.0379 -8.85% 0.4284 0.4284 0.3859
    Dec 4, 2023 0.4025 -0.0299 -6.91% 0.4324 0.4389 0.3984
    Dec 1, 2023 0.4284 -0.0100 -2.28% 0.4384 0.4434 0.4185
    Nov 30, 2023 0.4238 -0.0246 -5.49% 0.4484 0.4525 0.4195
    Nov 29, 2023 0.4484 0.0042 0.95% 0.4442 0.4532 0.4384
    Nov 28, 2023 0.4340 -0.0244 -5.32% 0.4584 0.4626 0.4284
    Nov 27, 2023 0.4584 -0.0100 -2.13% 0.4684 0.4885 0.4574
    Nov 24, 2023 0.4604 0.0020 0.44% 0.4584 0.4733 0.4534
    Nov 22, 2023 0.4614 0.0230 5.25% 0.4384 0.4700 0.4384
    Nov 21, 2023 0.4544 -0.0190 -4.01% 0.4734 0.4858 0.4486
    Nov 20, 2023 0.4684 0.0100 2.18% 0.4584 0.4690 0.4312
    Nov 17, 2023 0.4484 0.0000 0.00% 0.4484 0.4543 0.4346
    Nov 16, 2023 0.4581 0.0097 2.16% 0.4484 0.4581 0.4350
    Nov 15, 2023 0.4384 -0.0272 -5.84% 0.4656 0.4656 0.4284
    Nov 14, 2023 0.4359 -0.0225 -4.91% 0.4584 0.4686 0.4284
    Nov 13, 2023 0.4589 0.0255 5.88% 0.4334 0.4681 0.4321
    Nov 10, 2023 0.4383 0.0389 9.74% 0.3994 0.4383 0.3884

    Clene Inc. Events

    Time (UTC) Country Event
    Monday, March 11, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q4 2023 Clene Inc. Earnings Release
    Q4 2023 Clene Inc. Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0.473 0.723 0.206 0 0
    Total Operating Expense 48.882 50.053 20.96 0.5883 0.32394
    Selling/General/Admin. Expenses, Total 16.707 21.896 5.051 0.5883 0.32394
    Operating Income -48.409 -49.33 -20.754 -0.5883 -0.32394
    Net Income Before Taxes -29.918 -10.168 -18.871 0.2687 0.01943
    Net Income After Taxes -29.918 -9.74 -19.277 0.2687 0.01943
    Net Income Before Extra. Items -29.918 -9.74 -19.277 0.2687 0.01943
    Net Income -29.918 -9.74 -19.277 0.2687 0.01943
    Income Available to Common Excl. Extra. Items -29.918 -9.74 -19.277 -0.45022 -0.27731
    Income Available to Common Incl. Extra. Items -29.918 -9.74 -19.277 -0.45022 -0.27731
    Diluted Net Income -29.918 -9.74 -19.277 -0.45022 -0.27731
    Diluted Weighted Average Shares 65.2047 61.5585 17.504 2.10595 1.35724
    Diluted EPS Excluding Extraordinary Items -0.45883 -0.15822 -1.10129 -0.21378 -0.20432
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -0.46527 -0.16507 -1.08313 -0.21378 -0.20432
    Interest Income (Expense), Net Non-Operating 12.54 33.083 11.738 0.85701 0.34337
    Total Adjustments to Net Income 0 -0.71892 -0.29674
    Revenue 0.473 0.723 0.206
    Cost of Revenue, Total 0.026 0.289 0.065
    Gross Profit 0.447 0.434 0.141
    Research & Development 31.13 27.616 14.304
    Depreciation / Amortization 1.019 0.9 1
    Unusual Expense (Income) 0 -0.648 0.54
    Gain (Loss) on Sale of Assets 0.42 0 0.051
    Other, Net 5.531 6.079 -9.906
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0.269 0.107 0.234 0.174 0.035
    Revenue 0.269 0.107 0.234 0.174 0.035
    Cost of Revenue, Total 0.066 0.005 0.007 0.019 0
    Gross Profit 0.203 0.102 0.227 0.155 0.035
    Total Operating Expense 10.605 10.839 11.907 9.979 13.63
    Selling/General/Admin. Expenses, Total 3.857 3.372 4.063 3.49 4.397
    Research & Development 6.24 7.06 7.533 6.237 8.946
    Depreciation / Amortization 0.442 0.402 0.304 0.233 0.287
    Unusual Expense (Income) 0 0
    Operating Income -10.336 -10.732 -11.673 -9.805 -13.595
    Interest Income (Expense), Net Non-Operating -0.059 -0.949 8.268 -2.448 7.559
    Other, Net -14.748 -0.089 2.351 1.277 1.502
    Net Income Before Taxes -25.143 -11.77 -1.054 -10.976 -4.534
    Net Income After Taxes -25.143 -11.77 -1.054 -10.976 -4.534
    Net Income Before Extra. Items -25.143 -11.77 -1.054 -10.976 -4.534
    Net Income -25.143 -11.77 -1.054 -10.976 -4.534
    Income Available to Common Excl. Extra. Items -25.143 -11.77 -1.054 -10.976 -4.534
    Income Available to Common Incl. Extra. Items -25.143 -11.77 -1.054 -10.976 -4.534
    Diluted Net Income -25.143 -11.77 -1.054 -10.976 -4.534
    Diluted Weighted Average Shares 86.0504 76.0497 71.1144 63.5089 63.3353
    Diluted EPS Excluding Extraordinary Items -0.29219 -0.15477 -0.01482 -0.17283 -0.07159
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.29219 -0.15477 -0.01482 -0.17283 -0.07159
    Gain (Loss) on Sale of Assets 0 0 0 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 29.195 54.583 62.989 0.47699 0.79048
    Cash and Short Term Investments 23.315 50.288 59.275 0.42945 0.74378
    Cash 18.332 50.288 59.275 0.42945 0.74378
    Other Current Assets, Total 2.871 0.169 0.112 0
    Total Assets 44.493 63.063 68.243 48.7772 47.161
    Total Current Liabilities 13.857 6.026 11.668 1.417 0.22224
    Accrued Expenses 4.351 3.957 4.154 0.10736 0.11523
    Notes Payable/Short Term Debt 0 0 0 0.92 0
    Other Current Liabilities, Total 0 6.2 0.38965 0.10701
    Total Liabilities 41.256 50.466 67.902 3.257 2.06224
    Total Long Term Debt 19.287 19.179 2.154 0 0
    Total Equity 3.237 12.597 0.341 45.5202 45.0988
    Common Stock 0.007 0.006 0.006 40.5204 40.0989
    Additional Paid-In Capital 196.246 175.659 153.571 4.53411 4.95558
    Retained Earnings (Accumulated Deficit) -193.219 -163.301 -153.561 0.28575 0.01704
    Total Liabilities & Shareholders’ Equity 44.493 63.063 68.243 48.7772 47.161
    Total Common Shares Outstanding 74.7596 62.3121 59.5262 5.965 5.965
    Prepaid Expenses 2.472 1.242 0.04754 0.04669
    Other Long Term Assets, Total 0.058 0.058 48.3002 46.3705
    Other Liabilities, Total 8.112 25.261 53.82 1.84 1.84
    Preferred Stock - Non Redeemable, Net 0 0 0
    Other Equity, Total 0.203 0.233 0.325 0.17994 0.02718
    Total Receivables, Net 2.966 1.613 2.169
    Accounts Receivable - Trade, Net 0.189 0.049 0.021
    Total Inventory 0.043 0.041 0.191
    Property/Plant/Equipment, Total - Net 15.24 8.422 5.254
    Property/Plant/Equipment, Total - Gross 20.513 12.719 8.632
    Accumulated Depreciation, Total -5.273 -4.297 -3.378
    Accounts Payable 3.014 1.923 1.124
    Current Port. of LT Debt/Capital Leases 6.492 0.146 0.19
    Long Term Debt 19.253 19.082 1.949
    Capital Lease Obligations 0.034 0.097 0.205
    Deferred Income Tax 0 0.26
    Short Term Investments 4.983
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 46.446 53.371 24.822 29.195 21.486
    Cash and Short Term Investments 42.113 49.243 18.442 23.315 16.233
    Cash 42.113 49.243 18.442 18.332 7.267
    Total Receivables, Net 1.148 1.019 3.114 2.966 1.724
    Accounts Receivable - Trade, Net 0.064 0.161 0.063 0.189 0.126
    Total Inventory 0.104 0.052 0.088 0.043 0.038
    Prepaid Expenses
    Other Current Assets, Total 3.081 3.057 3.178 2.871 3.491
    Total Assets 60.433 67.845 39.888 44.493 36.004
    Property/Plant/Equipment, Total - Net 13.929 14.416 15.008 15.24 14.46
    Property/Plant/Equipment, Total - Gross 20.448 20.518 20.672 20.513 19.393
    Accumulated Depreciation, Total -6.519 -6.102 -5.664 -5.273 -4.933
    Total Current Liabilities 15.268 5.735 16.876 13.857 6.154
    Accounts Payable 1.889 0.846 0.608 3.014 3.454
    Accrued Expenses 3.747 4.827 6.441 4.351 2.603
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 9.632 0.062 9.827 6.492 0.097
    Other Current Liabilities, Total
    Total Liabilities 39.027 46.312 41.515 41.256 45.323
    Total Long Term Debt 16.65 25.839 16.623 19.287 20.534
    Long Term Debt 16.65 25.839 16.62 19.253 20.489
    Capital Lease Obligations 0 0 0.003 0.034 0.045
    Deferred Income Tax
    Other Liabilities, Total 7.109 14.738 8.016 8.112 18.635
    Total Equity 21.406 21.533 -1.627 3.237 -9.319
    Common Stock 0.013 0.013 0.008 0.007 0.006
    Additional Paid-In Capital 253.854 251.478 203.133 196.246 182.76
    Retained Earnings (Accumulated Deficit) -232.55 -230.132 -204.989 -193.219 -192.165
    Other Equity, Total 0.089 0.174 0.221 0.203 0.08
    Total Liabilities & Shareholders’ Equity 60.433 67.845 39.888 44.493 36.004
    Total Common Shares Outstanding 128.412 128.401 77.9874 74.7596 63.542
    Other Long Term Assets, Total 0.058 0.058 0.058 0.058 0.058
    Short Term Investments 0 0 0 4.983 8.966
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -29.918 -9.74 -19.277 0.2687 0.01943
    Cash From Operating Activities -39.011 -34.624 -18.929 -0.59697 -0.20537
    Changes in Working Capital -1.428 0.703 -2.874 -0.00872 0.11854
    Cash From Financing Activities 17.249 27.112 69.534 0.28264 46.9492
    Issuance (Retirement) of Stock, Net 11.77 0.454 66.962 0 48.175
    Issuance (Retirement) of Debt, Net 5.56 19.843 6.583 0.28264
    Net Change in Cash -31.956 -8.929 50.487 -0.31434 0.74378
    Non-Cash Items -8.684 -26.282 1.999 -0.85695 -0.34334
    Cash From Investing Activities -10.164 -1.332 -0.387 0 -46
    Other Investing Cash Flow Items, Total -4.985 0 -46
    Financing Cash Flow Items -0.081 6.815 -4.011 0 -1.22585
    Cash From Operating Activities 1.019 0.955 0.963
    Deferred Taxes 0 -0.26 0.26
    Cash Interest Paid 2.32 1.095 0.039
    Capital Expenditures -5.179 -1.332 -0.387
    Foreign Exchange Effects -0.03 -0.085 0.269
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -11.77 -29.918 -28.864 -17.888 -13.354
    Cash From Operating Activities -9.218 -39.011 -31.295 -22.814 -13.084
    Cash From Operating Activities 0.402 1.019 0.715 0.482 0.195
    Deferred Taxes 0 0 0 0
    Non-Cash Items 3.042 -8.684 -0.65 -4.718 2.148
    Cash Interest Paid 0.982 2.32 1.646 1.013 0.493
    Changes in Working Capital -0.892 -1.428 -2.496 -0.69 -2.073
    Cash From Investing Activities 4.722 -10.164 -12.446 -20.857 -24.522
    Capital Expenditures -0.278 -5.179 -3.478 -1.824 -0.936
    Cash From Financing Activities 4.588 17.249 0.875 0.783 0.235
    Financing Cash Flow Items -0.081 -0.002 -0.13 0
    Issuance (Retirement) of Stock, Net 4.266 11.77 0.284 0.284 0.267
    Issuance (Retirement) of Debt, Net 0.322 5.56 0.593 0.629 -0.032
    Foreign Exchange Effects 0.018 -0.03 -0.155 -0.147 0.013
    Net Change in Cash 0.11 -31.956 -43.021 -43.035 -37.358
    Other Investing Cash Flow Items, Total 5 -4.985 -8.968 -19.033 -23.586
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    General Resonance, L.L.C. Corporation 12.1174 15560212 0 2023-03-13 LOW
    SymBiosis Capital Management, LLC Venture Capital 10.1384 13018908 7500000 2023-09-08 LOW
    AK Holding Co LC Corporation 5.4143 6952635 792079 2023-03-13 LOW
    Matlin (David J.) Individual Investor 5.4073 6943684 1500000 2023-06-16 LOW
    AWM Investment Company, Inc. Investment Advisor/Hedge Fund 3.8937 5000000 5000000 2023-06-30 LOW
    Vivo Capital, LLC Venture Capital 3.5204 4520622 4520622 2023-06-30 LOW
    AIGH Capital Management, LLC. Private Equity 3.4692 4454907 4454907 2023-06-30 MED
    Acuta Capital Partners, LLC Hedge Fund 3.3025 4240846 4240846 2023-06-30 HIGH
    4life Research, L.L.C. Corporation 3.1126 3996895 -1 2023-03-13 LOW
    Kensington Investments, L.P. Corporation 2.4662 3166891 160221 2023-03-13 LOW
    United Therapeutics Corp Corporation 2.2346 2869517 -786575 2022-12-31
    Mosca (Alison) Individual Investor 1.9686 2527921 887182 2023-03-13 LOW
    Gay (Jonathon) Individual Investor 1.7316 2223593 990099 2023-03-13 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.7135 2200377 1079601 2023-06-30 LOW
    Alyeska Investment Group, L.P. Hedge Fund 1.5366 1973135 1973135 2023-06-30 HIGH
    Citadel Advisors LLC Hedge Fund 1.4433 1853363 1853363 2023-06-30 LOW
    Worth Venture Partners, LLC Investment Advisor/Hedge Fund 1.1546 1482593 1482593 2023-06-30 HIGH
    Hudson Bay Capital Management LP Hedge Fund 1.0736 1378600 1378600 2023-06-30 HIGH
    Stevens (John Henry) Individual Investor 0.7078 908857 316455 2023-06-26 LOW
    Wilcox (Reed N) Individual Investor 0.4479 575145 0 2023-03-13 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Clene Inc. Company profile

    Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson''s; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company''s products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah.
    Industry: Bio Therapeutic Drugs

    6550 South Millrock Drive, Suite G50
    SALT LAKE CITY
    UTAH 84121
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    XRP/USD

    0.67 Price
    -0.380% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading